Bifidobacterium infantis – BI02 (DSM 24687, formerly MB287)

Discover characteristics, functionalities and scientific support of Bifidobacterium infantis – BI02 (DSM 24687, formerly MB287).

Cholesterol management

Thearapeutical Area(s): Cardiometabolic

Age/Gender: Adults

Is this strain or blend in your company's portfolio? Contact us.

Cardiovascular health • Cholesterol lowering

Internal in vitro data on Bile Salt Hydrolase (BSH) production available upon request

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

Read MicrobiomePost’s Privacy Policy

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

Bifidobacterium infantis – BI02 (DSM 24687, formerly MB287)

Scientific reference(s)